Canopy Growth (TSX:WEED) Stock: Can It Lead the $70 Billion Cannabis Market?

Can Canopy Growth stock rebound in the second half of 2020?

| More on:

Leading cannabis company Canopy Growth (TSX:WEED)(NYSE:CGC) identified Canada, the U.S., and Germany as its core markets during the recent investor day call. Canopy Growth has forecast the global cannabis market to be valued at $70 billion by 2023.

It forecast the total addressable market (TAM) at over $60 billion in the U.S. in case the product is declared legal at the federal level. It also forecasts the U.S. CBD market at $10 billion. The marijuana giant plans to launch 40 CBD products south of the border and leverage its position as a leader in this segment.

What are the challenges outlined by Canopy Growth?

While the cannabis industry is expected to grow at a rapid pace, Canopy Growth has outlined several issues plaguing marijuana producers. It claims that marijuana is not accepted as a retail product despite its legalization. Several users are still hesitant to start using these products as a result. This continues to impact demand for most licensed producers.

Another issue that continues to impact pot producers is a thriving black market. The company estimates just 40% of Canada’s cannabis users buy products from licensed producers.

How does Canopy Growth aim to surpass these challenges?

Canopy Growth revealed that it has taken multiple approaches to tackle these problems — one approach is to focus on introducing cannabis-infused alcohol drinks to consumers. It continues to focus on innovation and develop products such as vapes and gels to generate demand across product categories.

Beverage giant Constellation Brands has a 38% stake in Canopy Growth. Canopy CEO David Klein served as the CFO of Constellation Brands prior to this transition. Canopy is well poised to lead the cannabis-infused beverage market and has shipped over 500,000 beverage drinks since they were launched recently.

Canopy has forecast Canada’s beverage drinks market at $26 billion and expects to account for 5% of this space, according to a Yahoo! Finance report. This indicates an annual revenue of $1.3 billion for the company. In fiscal 2020, Canopy generated $399 million in total sales and this figure is expected to reach $539.5 million in 2021.

In order to offset lower demand due to the above-mentioned reasons as well as a slower-than-expected rollout of retail stores in major Canadian provinces, Canopy Growth is focused on reducing operating costs.

Since the start of 2020, Canopy Growth has laid off 800 employees as it aims to improve profit margins. The company expects this headcount reduction and cost-saving efforts will help it save $20 million on an annualized basis.

What next for investors?

Canopy Growth stock is trading at $23.3, which is 57% below its 52-week high and 70% below record highs. Most cannabis companies have lost massive value due to structural issues plaguing the pot industry.

Canopy Growth stock is the largest marijuana company with a market cap of $8.6 billion. It is valued at 16 times forward sales and continues to post an adjusted loss.

The pot heavyweight will have to reduce losses and drastically improve profit margins as well as grow its top-line at a rapid pace to support its lofty valuation.

The Motley Fool owns shares of and recommends Constellation Brands. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »